CA2598786A1 - Composition et procede d'augmentation de l'anabolisme des cellules musculaires - Google Patents

Composition et procede d'augmentation de l'anabolisme des cellules musculaires Download PDF

Info

Publication number
CA2598786A1
CA2598786A1 CA002598786A CA2598786A CA2598786A1 CA 2598786 A1 CA2598786 A1 CA 2598786A1 CA 002598786 A CA002598786 A CA 002598786A CA 2598786 A CA2598786 A CA 2598786A CA 2598786 A1 CA2598786 A1 CA 2598786A1
Authority
CA
Canada
Prior art keywords
alpha
dissolution
composition
phase
rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002598786A
Other languages
English (en)
Other versions
CA2598786C (fr
Inventor
Michele Molino
Joseph Macdougall
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Northern Innovations and Formulations Corp
Original Assignee
Multi Formulations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Multi Formulations Ltd filed Critical Multi Formulations Ltd
Priority to CA2598786A priority Critical patent/CA2598786C/fr
Publication of CA2598786A1 publication Critical patent/CA2598786A1/fr
Application granted granted Critical
Publication of CA2598786C publication Critical patent/CA2598786C/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/06—Anabolic agents
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Polymers & Plastics (AREA)
  • Neurology (AREA)
  • Mycology (AREA)
  • Food Science & Technology (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nutrition Science (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
CA2598786A 2007-09-11 2007-09-11 Composition et procede d'augmentation de l'anabolisme des cellules musculaires Expired - Fee Related CA2598786C (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CA2598786A CA2598786C (fr) 2007-09-11 2007-09-11 Composition et procede d'augmentation de l'anabolisme des cellules musculaires

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CA2598786A CA2598786C (fr) 2007-09-11 2007-09-11 Composition et procede d'augmentation de l'anabolisme des cellules musculaires

Publications (2)

Publication Number Publication Date
CA2598786A1 true CA2598786A1 (fr) 2008-12-16
CA2598786C CA2598786C (fr) 2012-01-03

Family

ID=40134902

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2598786A Expired - Fee Related CA2598786C (fr) 2007-09-11 2007-09-11 Composition et procede d'augmentation de l'anabolisme des cellules musculaires

Country Status (1)

Country Link
CA (1) CA2598786C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021198788A1 (fr) * 2020-03-30 2021-10-07 Compagnie Gervais Danone Compositions de lait fermenté destinées à être utilisées dans des procédés de supplémentation nutritionnelle

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2021198788A1 (fr) * 2020-03-30 2021-10-07 Compagnie Gervais Danone Compositions de lait fermenté destinées à être utilisées dans des procédés de supplémentation nutritionnelle

Also Published As

Publication number Publication date
CA2598786C (fr) 2012-01-03

Similar Documents

Publication Publication Date Title
AU2020203101B2 (en) Tyrosine hydroxylase inhibitors for treating intestinal hyperpermeability
JP2020504108A (ja) アミノ酸組成物および肝疾患の治療方法
CA2515293A1 (fr) Acide eicosapentaenoique utilise pour ameliorer le pronostic dans le traitement de l'hemorragie sous sous-arachnoidienne
RU2006132719A (ru) Способ повышения биологической доступности оспемифена
EP1283054A4 (fr) Medicaments permettant de traiter les complications du diabete et des neuropathies et utilisation de ces medicaments
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
JP2009242413A (ja) アミノ酸をベースとする医薬
HK1080689A1 (en) Compositions comprising short and long chain fattyacids and methods of their use for the management of body weight
IL179718A0 (en) Pharmaceutical composition containing irbesartan
WO2007012019A3 (fr) Medicaments contenant famotidine et ibuprofene, et administration desdits medicaments
RU2009126767A (ru) Производное 1-фенил-1-тио-d-глюцитола
NO20050667L (no) N-substituerte-1H-indol-5-propionsyreforbindelser som PPAR agonister nyttige for behandling av diabetes
WO2007056264A3 (fr) Methodes de traitement anticancereux avec des formulations d'un compose de platine a base de lipides d'une haute activite administrees par voie intraperitoneale
JP2007238598A5 (fr)
WO2011118976A3 (fr) Composition pharmaceutique pour la prévention ou le traitement d'une stéatose hépatique non alcoolique et procédé pour la prévention ou le traitement de la stéatose hépatique non alcoolique utilisant celle-ci
RU2007138582A (ru) Пероральные дозированные формы производных гемцитабина
EA200501819A1 (ru) Способы и фармацевтические композиции для достоверного достижения приемлемых уровней тестостерона в сыворотке
WO2008030830A3 (fr) Composition à libération prolongée et son procédé d'utilisation
CA2595363A1 (fr) Methodes et mareriaux a base de trans-clomiphene permettant de traiter la sterilite masculine
WO2004071156A3 (fr) Utilisation d'un acide comestible dans des formes posologiques pharmaceutiques solides a dispersion rapide
JP5048372B2 (ja) 育毛促進剤
HK1129071A1 (en) Use of an indazolemethoxyalkanoic acid for reducing triglyceride, cholesterol and glucose levels
CA2598786A1 (fr) Composition et procede d'augmentation de l'anabolisme des cellules musculaires
WO2005055933A3 (fr) Nouveau traitement et compositions
RU2353358C2 (ru) Производные прегабалина для лечения приливов

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed

Effective date: 20220912